Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | AHR | P35869 | 2/20 | 0.57 |
| ▸ | PLA2G2A | P14555 | 5/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.51 |
| ▸ | MAOA | P21397 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10478418 | 1.00 | MAPT (0.63) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15835950 | 1.00 | MAPT (0.63) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15835969 | 1.00 | MAPT (0.63) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL24171975 | 0.98 | MAPT (0.61) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL20706697 | 0.98 | MAPT (0.61) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL26311700 | 0.98 | MAPT (0.61) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL1636494 | 0.96 | MAPT (0.59) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL1636486 | 0.96 | MAPT (0.59) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL804741 | 0.96 | MAPT (0.59) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15836052 | 0.96 | MAPT (0.59) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-11444254-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2022-09-13 | — | — | US | disclosed |
| US-11358951-B2 | Π(PI)-conjugated compound, organic electroluminescence element material, light-emitting material, light-emitting thin film, organic electroluminescence element, display device, and illumination device | MERCK PATENT GMBH (DE) | 2022-06-14 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-10916716-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2021-02-09 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| EP-2513125-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011157790-A1 | ORGANIC ELECTRONIC DEVICES COMPRISING A LAYER OF A DIBENZOFURANE COMPOUND AND A 8-HYDROXYQUINOLINOLATO EARTH ALKALINE METAL, OR ALKALI METAL COMPLEX | BASF SE (DE) | 2011-12-22 | — | — | WO | disclosed |
| EP-2395573-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT | Konica Minolta Holdings, Inc. (JP) | 2011-12-14 | — | — | EP | disclosed |
| US-20110272687-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110272687-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-10 | — | — | US | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, DRD2 | MAPT 883/4885KDM4E 4587/4885ALDH1A1 2444/4885 |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | MAPT 893/4885KDM4E 4573/4885ALDH1A1 2588/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | MAPT 893/4885KDM4E 4573/4885ALDH1A1 2588/4885 |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | MAPT 893/4885KDM4E 4573/4885ALDH1A1 2588/4885 |
| US-11444254-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs | OCIAD1, OCIAD2, DRD2 | MAPT 893/4885KDM4E 4573/4885ALDH1A1 2588/4885 |
| US-10916716-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | MAPT 893/4885KDM4E 4573/4885ALDH1A1 2588/4885 |
| US-11358951-B2 | Π(PI)-conjugated compound, organic electroluminescence element material, light-emitting material, light-emitting thin film, organic electroluminescence element, display device, and illumination device | ZYX, OCIAD2, DRD1 | MAPT 3012/4885KDM4E 2680/4885ALDH1A1 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.